ArticleFrontiers in pharmacology2019

Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease.

Marloes Dankers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.